Skip to main content

Evogene Ltd.

corporate_fare Company Profile

Evogene Ltd.

EVGN·NASDAQ·Industrial Applications And Services·CIK 0001574565

Evogene Ltd. is a computational biology company operating in Israel, the United States, Europe, and Africa. The company is structured into three segments: Agriculture, Human Health, and Industrial Applications. In its Agriculture segment, Evogene engages in activities related to seed traits and ag-chemicals. For Human Health, the company designs novel small molecules for drug development, utilizing its ChemPass AI, a computational generative AI engine. It also has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD). The Industrial Applications segment focuses on the development and commercialization of castor bean seeds for industrial uses. Additionally, the company is involved with medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Evogene Ltd. (NASDAQ:EVGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors EVGN SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Evogene Finalizes Highly Dilutive $2.9M ATM Offering Amidst Delisting and Going Concern Risks
  • Evogene Establishes Highly Dilutive $2.9M ATM Offering Amidst Delisting Concerns
  • Subsidiary Biomica's Cancer Drug Shows Favorable Safety, Clinical Activity in Phase 1 Study
  • Evogene Reports 86% Q1 Revenue Plunge, $5.87M Net Loss; Raises Capital via Warrants
  • Selling Shareholder Offers 2.45M Shares Amidst Delisting Concerns

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$3.85M
Net Income
-$7.83M
Diluted EPS
$1.08
Op. Cash Flow
-$13.5M
Free Cash Flow
-$13.64M
Gross Profit
-$241K
Operating Income
-$14.03M
Cash & Equivalents
$12.43M
Debt / Equity
0.00×
Net Margin
-203.1%
Shares Outstanding
8.72M sh
Source: 20-F · filed 2026-03-26 · accession 0001178913-26-001767

Insider Transactions

EVGN files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with E →
$0.5723 -0.01% today
52-week range · as of 2026-06-11 $0.5206 – $2.03
Market cap
$7.07M
Volume
127.6K (0.1× avg)
3-mo avg 980.7K
Live data · 2026-06-14 02:15 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed EVGN - Latest Insights

EVGN
Jun 11, 2026, 4:05 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.591
Real-time Price: $0.5723 info
Change: -$0.0187 (-3%) info
Market Cap: $7.067M info
EVGN
Jun 11, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.598
Real-time Price: $0.5723 info
Change: -$0.0257 (-4%) info
Market Cap: $7.067M info
EVGN
Jun 02, 2026, 7:15 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $0.940
Real-time Price: $0.5723 info
Change: -$0.3677 (-39%) info
Market Cap: $7.067M info
EVGN
May 21, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $0.7199
Real-time Price: $0.5723 info
Change: -$0.1476 (-21%) info
Market Cap: $7.067M info
EVGN
May 20, 2026, 8:45 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.710
Real-time Price: $0.5723 info
Change: -$0.1377 (-19%) info
Market Cap: $7.067M info
EVGN
May 20, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7186
Real-time Price: $0.5723 info
Change: -$0.1463 (-20%) info
Market Cap: $7.067M info
EVGN
May 18, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.6999
Real-time Price: $0.5723 info
Change: -$0.1276 (-18%) info
Market Cap: $7.067M info
EVGN
Apr 02, 2026, 4:03 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.7902
Real-time Price: $0.5723 info
Change: -$0.2179 (-28%) info
Market Cap: $7.067M info
EVGN
Mar 26, 2026, 4:30 PM EDT
Filing Type: F-3
Importance Score:
9
Price at Filing: $0.820
Real-time Price: $0.5723 info
Change: -$0.2477 (-30%) info
Market Cap: $7.067M info
EVGN
Mar 26, 2026, 4:00 PM EDT
Filing Type: 20-F
Importance Score:
9
Price at Filing: $0.820
Real-time Price: $0.5723 info
Change: -$0.2477 (-30%) info
Market Cap: $7.067M info
EVGN
Mar 05, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8642
Real-time Price: $0.5723 info
Change: -$0.2919 (-34%) info
Market Cap: $7.067M info
EVGN
Mar 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.8408
Real-time Price: $0.5723 info
Change: -$0.2685 (-32%) info
Market Cap: $7.067M info
EVGN
Feb 25, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.8383
Real-time Price: $0.5723 info
Change: -$0.266 (-32%) info
Market Cap: $7.067M info
EVGN
Feb 11, 2026, 4:00 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.01
Real-time Price: $0.5723 info
Change: -$0.4378 (-43%) info
Market Cap: $7.067M info
EVGN
Feb 04, 2026, 8:00 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.03
Real-time Price: $0.5723 info
Change: -$0.4577 (-44%) info
Market Cap: $7.067M info
EVGN
Jan 15, 2026, 4:00 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.5723 info
Change: -$0.4877 (-46%) info
Market Cap: $7.067M info